APA

Iyengar S., Hipskind P. A., Gehlert D. R., Schober D., Lobb K. L., Nixon J. A., Helton D. R., Kallman M. J., Boucher S., Couture R., Li D. L. & Simmons R. M. (19970317). LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. : The Journal of pharmacology and experimental therapeutics.

Chicago

Iyengar S, Hipskind P A, Gehlert D R, Schober D, Lobb K L, Nixon J A, Helton D R, Kallman M J, Boucher S, Couture R, Li D L and Simmons R M. 19970317. LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. : The Journal of pharmacology and experimental therapeutics.

Harvard

Iyengar S., Hipskind P. A., Gehlert D. R., Schober D., Lobb K. L., Nixon J. A., Helton D. R., Kallman M. J., Boucher S., Couture R., Li D. L. and Simmons R. M. (19970317). LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. : The Journal of pharmacology and experimental therapeutics.

MLA

Iyengar S, Hipskind P A, Gehlert D R, Schober D, Lobb K L, Nixon J A, Helton D R, Kallman M J, Boucher S, Couture R, Li D L and Simmons R M. LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. : The Journal of pharmacology and experimental therapeutics. 19970317.